Senda Biosciences Funding: $226M Raised, Series C (2022)
Senda Biosciences is based in Cambridge. It has raised $226M in total funding. Latest round: Series C.
Senda Biosciences funding overview
Senda Biosciences is based in Cambridge. Senda Biosciences has raised $226M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2022. The round record for Senda Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Flagship Pioneering, Qatar Investment Authority, Samsung Life Science Fund, Stage 1 Ventures, Bluwave Capital, Longevity Vision Fund and 4 others. 10 distinct backers are named across the disclosed rounds.
Senda Biosciences has raised $226M in total disclosed funding across the rounds on record.
Who has invested in Senda Biosciences?
Flagship Pioneering, Qatar Investment Authority, Samsung Life Science Fund, Stage 1 Ventures, Bluwave Capital, Longevity Vision Fund are named among the investors backing Senda Biosciences.
What was the latest Senda Biosciences funding round?
The most recent disclosed round is a Series C, announced in August 2022.
Where is Senda Biosciences based?
Senda Biosciences is based in Cambridge.
When did Senda Biosciences last raise?
The last disclosed Senda Biosciences round closed in August 2022 at Series C.
Totals shown for Senda Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
